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Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UKObjective. Dynamic MR perfusion imaging can detect cerebral perfusion deficits resulting from severe internal carotid
artery (ICA) stenosis. It is unknown, however, whether moderate ICA stenosis (50–69%) also causes haemodynamic
disturbance. We investigated whether cerebral perfusion deficits were detectable in patients with moderate ICA stenosis.
Methods. Eighteen patients underwent T2* weighted cerebral MR perfusion imaging with a gadolinium based contrast
agent. Differences in mean time to peak (mTTP) and relative cerebral blood volume (rCBV) between cerebral hemispheres
were calculated for middle cerebral artery territory regions by a reader blinded to the angiographic and clinical findings.
Results. There were significant differences in mTTP between cerebral hemispheres in 15 patients with a mean inter-
hemispheric delay in mTTP of 0.49 s (95% confidence intervals, 0.25 and 0.72 s) which was statistically significant (p!
0.001). In 1 patient with bilateral moderate stenosis there was no difference in mTTP.
Conclusions. Moderate ICA stenosis results in significant ipsilateral cerebral perfusion delays detectable by dynamic
susceptibility MRI. Follow-up studies might reveal whether these delays improve following carotid endarterectomy.Keywords: Cerebral perfusion; Magnetic resonance; Carotid stenosis; Moderate.Introduction
The benefits of carotid endarterectomy (CEA) for
symptomatic internal carotid artery (ICA) stenosis
have been demonstrated in patients with high grade
stenosis,1 and in selected patients with moderate ICA
stenosis.2 Selection for surgery, which remains the
gold standard treatment, based solely on luminal
measurements of stenosis may not adequately reflect
the burden of atherosclerotic disease because of vessel
wall remodelling,3 which in turn may have conse-
quences for vascular compliance and blood flow.4
Current trends in stratifying risk in patients with ICA
stenosis have moved towards using non-invasive
imaging modalities to identify high-risk atheromatous
plaques, more prone to rupture and consequently
thrombo-embolic occlusion.5 These emerging tech-
niques have the potential to offer patient-specificing author. Jonathan H. Gillard FRCR, University
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accounts for the majority of ischaemic strokes, a
smaller but significant number occur as a result of
haemodynamic insufficiency.6,7 Dynamic MR imaging
has been shown to accurately identify differences in
cerebral perfusion parameters in patients with unilat-
eral severe ICA stenosis,8,9 and further studies have
shown that some of the benefit of CEA may relate to
normalization of cerebral vascular haemodynamics
following surgery.9,10 Although therapy for patients
with high grade stenosis is established, the same is not
true of patients with moderate stenosis of the ICA in
whom the benefits of CEA are not widely estab-
lished.11 It is not known whether there are inter-
hemispheric differences in cerebrovascular perfusion
parameters in symptomatic patients with moderate
ICA stenosis and consequently it is unknown whether
any potential benefit following CEA might be a
consequence of restitution of altered cerebral haemo-
dynamics, or purely due to reduction in the risk of
thrombo-embolism. In the present study, we investi-
gated whether patients with moderate internal carotid
artery (ICA) stenosis had evidence of ipsilateralEur J Vasc Endovasc Surg 29, 52–57 (2005)
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by dynamic MR imaging using a gadolinium chelate
MR contrast agent.MethodsPatient selection
Eighteen recently symptomatic patients were
recruited following conventional digital subtraction
angiography which confirmed moderate (50–69%)
ICA stenosis, measured by accepted criteria.1 Patients
with co-existent contralateral severe ICA stenosis
(R70%) were excluded. Angiographic measurements
made by radiographers were independently con-
firmed by an experienced reader who also reviewed
available cerebral angiograms to identify any intra-
cranial arterial stenosis; patients with MCA stenosis
were excluded from the study. Standard MR exclusion
criteria were applied. The study received approval
from the Local Research Ethics Committee and all
patients gave written informed consent to participate.Dynamic MR perfusion studies
All magnetic resonance studies were performed using
a 1.5 T imaging system (Signa CV/I, GE, Milwaukee,
WI). Initially the following baseline sequences were
performed: axial fastT2W (TR 6000 ms, effective TE
106 ms, ETLZ24, field of view 22!16 cm2, slice
thickness 6.0 mm with 1.0 mm gap, matrix 320!256
and 2 NEX); axial fast FLAIR (TR 9000 ms, effective TE
158 ms, TI 2200 ms, field of view 22!22 cm2, slice
thickness 6.0 mm with 1.0 mm gap, matrix 256!192
and 1 NEX); single-shot diffusion weighted spin echo-
EPI (SE-EPI) (TR 10,000 ms, effective TE 70 ms, field of
view 28!22 cm, slice thickness 6.0 mm with 1.0 mm
gap, matrix 128!128, 1 NEX and a b-value of 1000 s
mmK2). If after these sequences, there was evidence of
space occupying lesions or large ischaemic regions, the
perfusion study was not performed. Dynamic suscep-
tibility contrast imaging (DSCI) was performed using
a multi-phase single-shot SE-EPI imaging sequence
(TR 1500 ms, effective TE 65 ms, field of view 22!
22 cm2, slice thickness 6.0 mm with 1.0 mm gap,
matrix 96!96 and 1 NEX). Forty-two temporal phases
were obtained for each of 12 axial slices. After 10
baseline images 0.1 mmol gadolinium chelate (Gado-
vistw, Schering)/kg body weight was administered by
power injector (Spectris Medrad, Maastricht, The
Netherlands) at 3 ml/s in to the antecubital veinusing a 16G venflon, and flushed through with 20 ml
of normal saline.Image analysis
The post-processing of dynamic susceptibility contrast
imaging has been extensively described.12 For a spin
echo sequence the relative change in signal at timeZt
(St) compared to timeZ0 (S0) is attributed to the
increased T2 relaxation induced by the concentration
of the first pass of the non-diffusible contrast agent (Ct)
through the cerebral vasculature. Ct was calculated for
each voxel according to equation S0 was created by
averaging images 5–10 to reduce noise propagation
through the time series. This model assumes that CtZ
k/DT2. The constant k is assumed to be constant
through all tissues in the brain, but in actual fact will
vary from voxel to voxel according to the local
hematocrit, capillary geometry, brain density, and the
type of perfusion sequence. This model also ignores
changes in T1 relaxation times.
13 These extensive
unknowns prevent calculation of true values of
absolute perfusion from the dynamic susceptibility
cerebral imaging (DSCI) MR technique.12
Time to peak (TTP) parametric maps were created
by searching for the time point of the greatest signal
change after the arrival of the arterial bolus. No fitting
of bolus curve models such as the gamma variate
curve, or interpolation was used, since gamma variate
fitting may be inaccurate at low signal to noise levels,
andmay not be an appropriate model of the bolus time
curve in pathological circulations.
The relative cerebral blood volume (rCBV) was
calculated as the area under Ct, starting with the
arrival of the arterial bolus, and finishing prior to the
onset of recirculation.14Segmentation and co-registration
We utilised widely available image templates to
segment images into the territories of the middle
cerebral artery and posterior cerebral arteries. Co-
registration of perfusion images into the image space
was performed using the vtkview software package
(Computer Imaging Science Group, King’s College,
London, UK).15 An automated non-rigid body co-
registration utilising the normalized mutual infor-
mation algorithmwas used to co-register the perfusion
images with image templates provided with the SPM
software package (Wellcome Department of Imaging
Neuroscience, University College, London, UK).
Templates for automatic anatomical labelling16
consist of images where a particular pixel valueEur J Vasc Endovasc Surg Vol 29, January 2005
R. A. Trivedi et al.54corresponds to an anatomical location; for example
pixels with the numerical value of 57 correspond to the
left post central gyrus, 58 to the right post central
gyrus (templates supplied with MRIcro software
package, Department of Psychology, University of
South Carolina, SC, USA). These template maps were
refined to include the white matter areas between the
cortex and the deep nuclei. Areas around the
paranasal sinuses were excluded from the analysis
due to susceptibility induced spatial distortions that
would potentially result in erroneous perfusion
values.
Tissue probability maps also supplied with SPM
were used to determine grey and white matter within
each vascular territory and exclude voxels likely to
include considerable partial volumes of cerebrospinal
fluid. A threshold probability of 50% was used to
threshold out voxels with partial volumes of other
tissues. Measurements of TTP and rCBV were calcu-
lated as average values within each territory i.e. mean
TTP (mTTP) and mean rCBV (mrCBV).Data analysis
For patients with moderate stenosis in one vessel and
moderate or minor (!50%) stenosis in the contral-
ateral ICA, the vessel with the greater stenosis was
considered the ‘stenosed’ vessel and the contralateral
vessel ‘lesser or non-stenosed’. Mean TTP (mTTP)
values and rCBV (mrCBV) values were calculated for
each patient by a reader blinded to the clinical
findings. Subsequently, the inter-hemispheric differ-
ences, in mTTP and mrCBV values for grey and white
matter, between the stenosed and lesser/non-stenosed
ICAs were calculated by an independent operator and
the mean and median inter-hemispheric delay deter-
mined. Ninety-five percentage confidence intervals
were calculated for the inter-hemispheric differences
in mTTP and mrCBV and statistical significance
determined using the Wilcoxan Rank test for non-
parametric data as the individual values did not
follow a normal distribution. A P value of !0.05 was
used to define statistical significance. All statistical
analysis was performed using SPSS software (version
10, Chicago, IL, USA).Fig. 1. Time to peak signal intensity curves, right (green) and
left (red), demonstrating delay (0.5 s) between hemispheres
in patient 11.Results
Of the 18 patients, 17 were male. The mean age was 72
years (range 57–82 years). Two patients became
claustrophobic during the perfusion study and did
not complete the examination. Fifteen of 16 patientsEur J Vasc Endovasc Surg Vol 29, January 2005had unilateral moderate ICA stenosis. Nine patients
had minor stenosis (!50%) of the contralateral ICA.
Ten patients had moderate stenosis of the left internal
carotid artery. The median ICA stenosis in the
stenosed vessel was 61% and in the contralateral
vessel was 16%. Cerebral angiograms were available
for review in 10 of 16 patients; in four of the other six
patient’s only reports of the cerebral angiograms were
available. None of these patients had evidence of
stenosis in either MCA or a cerebral angiogram
reporting suggesting MCA disease. The average time
from symptoms to study was 4.5 months (range, 0.5–7
months). From the initial baseline sequences, there
was no space occupying lesions or diffusion restriction
abnormalities. The FLAIR sequence in seven patients
revealed multiple bilateral small high signal lesions,
suggestive of white matter disease. There were no
qualitative differences in the appearance of these
lesions between hemispheres in these seven patients.
There was an inter-hemispheric delay in mTTP (Fig. 1)
in the middle cerebral artery territory in 15 of 16
patients (Table 1) with a mean delay in mTTP of 0.49 s
(95% CI, 0.25–0.72) which was statistically significant
(Wilcoxan Rank test, p!0.001). A typical ROI TTPmap
is displayed in Fig. 2. In one patient with bilateral
moderate stenosis, no difference in mTTP was
measured between the two cerebral hemispheres.
There were no significant differences in mrCBV
between the ipsilateral hemisphere supplied by the
stenosed ICA and the contralateral hemisphere being
supplied by the lesser/non-stenosed vessel in either
white or greymatter regions, with a mean difference in
mrCBV in grey matter of K0.51 (95% confidence
Table 1. Angiography findings and measurements of mTTP and mrCBV for individual patients
Subject Stenosed Lesser* mTTP (s)
(ste-
nosed)
mTTP (s)
(lesser*)
Delay
(s)†
rCBV
stenosed
(grey)
rCBV
lesser*
(grey)
rCBV
diff†
(grey)
rCBV
stenosed
(white
matter)
rCBV
lesser*
(white)
rCBV
diff†
(white)
2 63 35 16.88 16.77 0.11 26.89 28.12 K1.23 17.3 18.92 K1.62
3 60 0 11.31 11.18 0.13 31.79 32.55 K0.76 22.29 21.55 0.74
4 52 0 12.4 12.04 0.36 36.85 37.38 K0.53 23.93 23.9 0.03
7 61 45 13.33 12.42 0.91 25.56 27.9 K2.34 19.53 19.86 K0.33
8 61 35 11.95 11.89 0.06 23.05 23.77 K0.72 15.47 16.17 K0.7
9 50 0 11.52 11.25 0.3 20.31 20.53 K0.22 11.73 12.39 K0.66
10 50 35 14.31 13.04 1.27 26.07 25.71 0.36 18.81 18.15 0.66
11 61 43 12.07 11.57 0.5 25.07 23.62 1.45 15.83 15.9 K0.07
12 60 0 12.02 11.42 0.6 9.7 10.19 K0.49 6.95 7.07 K0.12
13 63 0 11.97 11.55 0.42 27.33 31.35 K4.02 18.65 18.07 0.58
14 64 62 11.46 11.46 0 44.62 45.49 K0.87 28.51 29.28 K0.77
15 64 0 10.52 10.2 0.32 23.45 22.39 1.06 15.05 15.29 K0.24
16 65 0 11.63 11.3 0.33 25.87 28.13 K2.26 16.6 17.4 K0.8
17 57 0 12.34 12.23 0.11 19.74 19.54 0.2 11.13 10.84 0.29
18 60 46 14.38 12.94 1.44 25.04 23.64 1.4 17.07 13.89 3.18
20 62 32 13.61 12.67 0.94 13.13 12.31 0.82 8.65 8.62 0.03
Median 61 16 12.05 11.73 0.39 25.32 24.74 K0.51 16.84 16.78 0.09
Mean 60 21 12.61 12.12 0.49 25.28 25.79 K0.51 16.72 16.71 0.01
P value‡ 0.001 0.28 0.48
* Lesser/non-stenosed vessel.
† Delay/difference between hemispheres of stenosed vs lesser/non-sten xosed vessels.
‡ Wilcoxan Rank test.
Fig. 2. Typical mTTP maps demonstrating inter-hemispheric
delay in regions supplied by themiddle cerebral artery (from
patient 11).
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interval, K0.5 to 0.52) in white matter regions.Discussion
It has been suggested that high resolution MR imaging
of the carotid bifurcation might refine selection for
carotid endarterectomy in patients with high grade
stenosis of the internal carotid artery, by identifying
patients with high-risk rupture prone atheromatous
plaques.17,18 High resolution MR imaging techniques
can provide structural information on plaque mor-
phology and composition.5,17 Dynamic MR perfusion
techniques have addressed some of the physiological
effects of stenosis producing carotid bifurcation
plaques in both symptomatic and asymptomatic
patients.19 Despite the emergence of this modality as
an assessment tool, there have been no reported data
on dynamic MR perfusion imaging in the assessment
of symptomatic patients with only moderate ICA
stenosis. In the present study, we have shown that
there are significant delays in mTTP likely attributable
to moderate stenosis in the ICA. The mean inter-
hemispheric delay in mTTP of 0.49 s was expectedly
less than the 0.89 s delay in bolus arrival time (BAT)
which has been previously described in patients with
more severe stenosis,8 although these are two different
perfusion parameters. No delay in mTTP was evident
in 1 patient in whom there was only a small difference
in the degree of stenosis as measured by angiography,Eur J Vasc Endovasc Surg Vol 29, January 2005
R. A. Trivedi et al.56which might explain this finding. Although we have
attributed the delay in mTTP to ICA stenosis, it must
be considered that intra-cranial atherothrombosis
within the MCA might also contribute to the delay in
mTTP, a possibility that we cannot completely rule out,
as the cerebral angiograms and/or reports were not
available for review in all patients. In those that were
viewed, however, there was no evidence of intracra-
nial stenosis. The lack of any significant differences in
mrCBV between hemispheres supplied by stenosed
and lesser/non-stenosed ICAs might be explained by
the development of extensive collateral branches in the
arterial tree, as the average time between symptoms
and the study (4.5 months) was sufficiently long
enough for this process to occur.Analysis methodology
We chose to define our region of interest using defined
anatomical regions rather than the single-slice ellip-
tical approach taken by others,19,20 as we felt that this
would bemore representative of total blood flow in the
defined arterial territories derived from the ICA and
negate any contribution to the mTTP from predomi-
nantly vertebro-basilar derived arterial vessels. This
type of segmentation is probabilitistic in nature,
having been created from the images of normal
subjects. Inter-individual variation is problematic in
fMRI studies when attempts to localise particular
activations to specific gyri are made. In this study,
however, the aim was simply to segment tissues
according to their vascular supply. Furthermore, this
approach allowed us to identify specific parenchymal
regions within the middle cerebral artery territory in
which delays in mTTP were more pronounced (data
not shown). Consequently, the regions that were
analysed were not hemispheric ‘mirror’ images but
moreover corresponded anatomically.Assessment of cerebral perfusion
The parameters of TTP and rCBV are only surrogate
markers and do not directly measure the true
physiological perfusion in ml/100 g/min. This dis-
tinction may explain the inability to demonstrate a
relationship between the degree of stenosis and the
magnitude of perfusion delay. Time to peak is a
composite of various influences including systemic
bolus dispersal, anastomotic flow, and flow in the
distal arterial tree.12 A delay in the time to peak may
reflect the increased path length of blood reaching the
contralateral cerebral hemisphere, but not represent a
reduction in the perfusion pressure. It is also likely thatEur J Vasc Endovasc Surg Vol 29, January 2005simple cross sectional measures of stenosis used here
and in the clinic are inadequate measures of the
hemodynamic consequences of carotid stenosis. A
more accurate scoring system may be needed that
takes into account elements such as the perfusion
pressure, length of stenosis, blood viscosity, turbulent
flow, and anastomotic flow. Despite this the time to
peak is a relatively robust measure since it does not
depend upon the relationship between contrast
concentration and signal change. Whilst this result is
consistent with previous studies,8,10,21,22 we conclude
that time to peak is a sensitive but non-specific
indicator of perfusion disturbances in carotid stenosis.Limitations
Although, we have shown that cerebral haemody-
namic disturbances exist in patients with moderate
ICA stenosis, we must note that our study has several
limitations. Firstly, it is conceivable that our study
population might not be pure in that some of the
patients might actually be re-graded as severely
stenosed by either alternative measurement criteria11
or indeed another reader. This is of particular note as
two quite distinct techniques were used in the two
largest studies from which the benefits of CEA were
established.1,11 In our unit all the measurements are
made according to the NASCET investigators report23
and thus within the population of patients with carotid
stenosis served by our institution there is consistency
of measurement technique. Furthermore, a recent
study of measurement consistency for carotid angio-
graphy in our unit revealed strong inter-observer
agreement.24 Additionally, although defining the
territory of the middle cerebral artery as the ROI for
both hemispheres ensured that we were recording the
effect of ICA stenosis, the territories were defined
according to Talaraich space parameters, a technique
itself with intrinsic variability in anatomical
classification.
Our data does not demonstrate any relationship
between the degree of stenosis and alterations in the
ratio of rCBV between each side. The range of rCBV
ratio measurements obtained was inconsistent with
the side and degree of stenosis, despite a highly
objective approach to tissue segmentation. This could
result from either inconsistent pathological change
between patients with moderate stenosis, anastomotic
low, or poor sensitivity of the magnetic resonance
technique to small rCBV changes. PreviousMR studies
noting positive results have only involved patients
with either severe or complete carotid stenosis.21,22
Until this issue is resolved by comparison of the two
Cerebral Perfusion in Moderate Carotid Stenosis 57MR techniques with an accepted standard such as
positron emission tomography, this result calls into
question the ability of MR techniques to monitor small
changes in CBV.Conclusions
Despite some of the limitations of DSC-MRI as a
diagnostic tool, we have shown that appreciable
differences in inter-hemispheric cerebral perfusion
exist in patients with moderate ICA stenosis. These
findings suggest that DSC-MRI could aid risk strati-
fication of individuals with moderate ICA stenosis, by
improving selection of suitable individuals for aggres-
sive therapies. The evaluation of a post-operative
DSC-MRI may offer an additional means by which the
benefit of CEA in patients with moderate stenosis may
be characterised.Acknowledgements
We are grateful to Drs Leif Ostergaard and Louise
Gyldensted, Arhus University Hospital, Arhus, Denmark
for providing the DSCI protocol, and Dr Charlie Hard-
ingham for guidance on the image analysis. Gadovistw was
supplied by Schering AG. PG is the Schering Professor of
Radiology at Sheffield University.References
1 Northern American Symptomatic Carotid Endarterectomy Trial
Collaborators. Beneficial effect of carotid endarterectomy in
symptomatic patients with high-grade carotid stenosis. N Engl
J Med 1991;325:445–453.
2 Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid
endarterectomy in patients with symptomaticmoderate or severe
stenosis. North American Symptomatic Carotid Endarterectomy
Trial Collaborators. N Engl J Med 1998;339:1415–1425.
3 Glagov S, Bassiouny HS, Sakaguchi Y et al. Mechanical
determinants of plaque modeling, remodeling and disruption.
Atherosclerosis 1997;131(Suppl):S13–S14.
4 Willens HJ, Davis W, Herrington DM et al. Relationship of
peripheral arterial compliance and standard cardiovascular risk
factors. Vasc Endovasc Surg 2003;37:197–206.
5 Yuan C,Mitsumori LM, Beach KW et al. Carotid atherosclerotic
plaque: noninvasive MR characterization and identification of
vulnerable lesions. Radiology 2001;221:285–299.
6 Warlow C, Dennis MS, Gijn JV et al.Stroke: a practical guide to
management. 2nd ed Oxford: Blackwell Publishing: 2001.
7 Warlow C, Sudlow C, Dennis M et al. Stroke. Lancet 2003;
362:1211–1224.8 Gillard JH, Hardingham CR, Kirkpatrick PJ et al. Evaluation
of carotid endarterectomy with sequential MR perfusion ima-
ging: a preliminary report. AJNR Am J Neuroradiol 1998;19:1747–
1752.
9 van der Grond J, Balm R, Kappelle LJ et al. Cerebral
metabolism of patients with stenosis or occlusion of the internal
carotid artery. A 1H-MR spectroscopic imaging study. Stroke
1995;26:822–828.
10 Gillard JH, Hardingham CR, Antoun NM et al. Evaluation of
carotid endarterectomy with sequential MR perfusion imaging: a
preliminary 12-month follow up. Clin Radiol 1999;54:798–803.
11 Randomised trial of endarterectomy for recently symptomatic
carotid stenosis: final results of the MRC European Carotid
Surgery Trial (ECST). Lancet 1998; 351: 1379–1387.
12 Calamante F, Gadian DG, Connelly A:. Quantification of
perfusion using bolus tracking magnetic resonance imaging in
stroke: assumptions, limitations, and potential implications for
clinical use. Stroke 2002;33:1146–1151.
13 Runge VM, Wells JW. Choice of metal ion and formulation
concentration for first-pass brain perfusion studies with mag-
netic resonance imaging at 1.5 tesla. Invest Radiol 1996;31:395–400.
14 Perthen JE, Calamante F, Gadian DG et al. Is quantification of
bolus tracking MRI reliable without deconvolution? Magn Reson
Med 2002;47:61–67.
15 Studholme C, Hill DL, Hawkes DJ. Automated three-dimen-
sional registration of magnetic resonance and positron emission
tomography brain images by multiresolution optimization of
voxel similarity measures. Med Phys 1997;24:25–35.
16 Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al.
Automated anatomical labeling of activations in SPM using a
macroscopic anatomical parcellation of the MNI MRI single-
subject brain. Neuroimage 2002;15:273–289.
17 Fayad ZA, Fuster V. Characterization of atherosclerotic plaques
by magnetic resonance imaging. Ann N Y Acad Sci 2000;902:173–
186.
18 Hatsukami TS, Ross R, Polissar NL et al. Visualization of
fibrous cap thickness and rupture in human atherosclerotic
carotid plaque in vivo with high-resolution magnetic resonance
imaging. Circulation 2000;102:959–964.
19 Soinne L, Helenius J, Tatlisumak T et al. Cerebral hemody-
namics in asymptomatic and symptomatic patients with high-
grade carotid stenosis undergoing carotid endarterectomy. Stroke
2003;34:1655–1661.
20 Kim JH, Lee EJ, Lee SJ et al. Comparative evaluation of cerebral
blood volume and cerebral blood flow in acute ischemic stroke by
using perfusion-weighted MR imaging and SPECT. Acta Radiol
2002;43:365–370.
21 Kim JH, Lee EJ, Lee SJ et al. Reliability of perfusion MR imaging
in symptomatic carotid occlusive disease. Cerebral blood
volume, mean transit time and time-to-peak. Acta Radiol 2002;
43:360–364.
22 Kluytmans M, van der Grond J, Viergever MA. Gray matter
and white matter perfusion imaging in patients with severe
carotid artery lesions. Radiology 1998;209:675–682.
23 North American Symptomatic Carotid Endarterectomy Trial.
Methods, patient characteristics, and progress. Stroke 1991;
22:711–720.
24 U-King-Im J, Trivedi RA, Graves MJ et al. Contrast-enhanced
MR angiography for carotid disease: diagnostic accuracy and
potential therapeutic impact. Neurology 2004;62(8):1282–1290.
Accepted 28 September 2004Eur J Vasc Endovasc Surg Vol 29, January 2005
